1

Cancer Monoclonal Antibodies: A Promising Class of Targeted Therapeutics

News Discuss 
Monoclonal antibodies (mAbs) are a class of biopharmaceutical drugs made by identical immune cells that are all clones of a unique parent cell. They can be designed to bind to very specific targets on cells, and they have various applications across many therapeutic areas. In oncology, mAbs have emerged as a major class of targeted cancer therapies in recent decades. Mechanism of A... https://articlescad.com/cancer-monoclonal-antibodies-a-targeted-approach-to-cancer-treatment-109254.html

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story